title: HIV-1 Genetic Variability in Cuba and Implications for Transmission and Clinical Progression.
abstract: INTRODUCTION Serological and molecular HIV-1 studies in Cuba have shown very low prevalence of seropositivity, but an increasing genetic diversity attributable to introduction of many HIV-1 variants from different areas, exchange of such variants among HIV-positive people with several coinciding routes of infection and other epidemiologic risk factors in the seropositive population. The high HIV-1 genetic variability observed in Cuba has possible implications for transmission and clinical progression. OBJECTIVE Study genetic variability for the HIV-1 env, gag and pol structural genes in Cuba; determine the prevalence of B and non-B subtypes according to epidemiologic and behavioral variables and determine whether a relationship exists between genetic variability and transmissibility, and between genetic variability and clinical disease progression in people living with HIV/AIDS. METHODS Using two molecular assays (heteroduplex mobility assay and nucleic acid sequencing), structural genes were characterized in 590 people with HIV-1 (480 men and 110 women), accounting for 3.4% of seropositive individuals in Cuba as of December 31, 2013. Nonrandom sampling, proportional to HIV prevalence by province, was conducted. Relationships between molecular results and viral factors, host characteristics, and patients' clinical, epidemiologic and behavioral variables were studied for molecular epidemiology, transmission, and progression analyses. RESULTS Molecular analysis of the three HIV-1 structural genes classified 297 samples as subtype B (50.3%), 269 as non-B subtypes (45.6%) and 24 were not typeable. Subtype B prevailed overall and in men, mainly in those who have sex with men. Non-B subtypes were prevalent in women and heterosexual men, showing multiple circulating variants and recombinant forms. Sexual transmission was the predominant form of infection for all. B and non-B subtypes were encountered throughout Cuba. No association was found between subtypes and transmission or clinical progression, although the proportion of deaths was higher for subtype B. Among those who died during the study period, there were no differences between subtypes in the mean time from HIV or AIDS diagnosis to death. CONCLUSIONS Our results suggest that B and non-B HIV-1 subtypes found in Cuba do not differ in transmissibility and in clinical disease progression. KEYWORDS HIV-1, AIDS, molecular epidemiology, transmissibility, clinical progression, subtypes, circulating recombinant forms, pathogenesis, Cuba.
authors.affiliation: AIDS Research Laboratory (LISIDA), Havana, Cuba. madeniba@infomed.sld.cu.
authors.forename: Madeline
authors.initials: M
authors.lastname: Blanco
authors.forename: Liuber Y
authors.initials: LY
authors.lastname: Machado
authors.forename: Héctor
authors.initials: H
authors.lastname: Díaz
authors.forename: Nancy
authors.initials: N
authors.lastname: Ruiz
authors.forename: Dania
authors.initials: D
authors.lastname: Romay
authors.forename: Eladio
authors.initials: E
authors.lastname: Silva
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D003462:Cuba / Q000453:epidemiology; D018450:Disease Progression; D005260:Female; D014644:Genetic Variation; D015658:HIV Infections / Q000453:epidemiology / Q000235:genetics* / Q000635:transmission*; D015497:HIV-1 / Q000235:genetics*; D020180:Heteroduplex Analysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D021161:Self-Sustained Sequence Replication